Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-20.32%
↑ 23% above average
Average (30q)
-26.51%
Historical baseline
Range
High:64.53%
Low:-380.03%
Volatility
-1676.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -20.32% |
| Q2 2025 | 27.51% |
| Q1 2025 | -12.74% |
| Q4 2024 | -109.98% |
| Q3 2024 | -16.50% |
| Q2 2024 | -6.67% |
| Q1 2024 | -11.29% |
| Q4 2023 | 9.08% |
| Q3 2023 | 20.47% |
| Q2 2023 | -29.04% |
| Q1 2023 | -4.64% |
| Q4 2022 | 4.79% |
| Q3 2022 | 3.13% |
| Q2 2022 | 0.01% |
| Q1 2022 | 7.95% |
| Q4 2021 | -12.76% |
| Q3 2021 | -69.61% |
| Q2 2021 | 0.03% |
| Q1 2021 | -118.30% |
| Q4 2020 | -80.14% |
| Q3 2020 | -58.96% |
| Q2 2020 | 22.94% |
| Q1 2020 | -27.31% |
| Q4 2019 | 64.53% |
| Q3 2019 | 48.28% |
| Q2 2019 | -35.01% |
| Q1 2019 | -37.29% |
| Q4 2018 | 0.00% |
| Q1 2018 | -380.03% |
| Q4 2017 | 0.00% |
| Q1 2017 | 0.00% |